SCM
KURA icon

Sterling Capital Management’s Kura Oncology KURA Stock Holding History

Sterling Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28K Sell
299
-2,388
-89% -$22.5K ﹤0.01% 2824
2026
Q1 		$21.8K Sell
2,687
-13,977
-84% -$120K ﹤0.01% 1988
2025
Q4 		$173K Buy
16,664
+11,100
+199% +$116K ﹤0.01% 1349
2025
Q3 		$49.2K Buy
5,564
+3,429
+161% +$24.4K ﹤0.01% 1756
2025
Q2 		$12.3K Buy
2,135
+2,060
+2,747% +$12.6K ﹤0.01% 1996
2025
Q1 		$495 Hold
75
– – ﹤0.01% 2958
2024
Q4 		$653 Hold
75
– – ﹤0.01% 3000
2024
Q3 		$1.47K Buy
+75
New +$1.52K ﹤0.01% 2345

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Sterling Capital Management's KURA Position: Q2 2026 in Review

Sterling Capital Management reduced its Kura Oncology (KURA) stake by 89% in Q2 2026, selling an estimated $22.5K and leaving 299 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Sterling Capital Management first reported a position in KURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $173K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Sterling Capital Management held 299 shares of Kura Oncology worth $3.28K as of Q2 2026.
  • Sterling Capital Management sold 2,388 Kura Oncology shares in Q2 2026, an estimated $22.5K.
  • Kura Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2824 holding.
  • Sterling Capital Management first reported a position in Kura Oncology in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Kura Oncology position peaked at $173K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.